➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Colorcon
Harvard Business School
AstraZeneca
Express Scripts

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

PREDNISOLONE ACETATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for prednisolone acetate and what is the scope of freedom to operate?

Prednisolone acetate is the generic ingredient in eighteen branded drugs marketed by Schering, Akorn, Bel Mar, Cent Pharms, Watson Labs, Pfizer, Eyevance, Novartis, Allergan, Taro, Alcon, Pharmafair, and Bausch And Lomb, and is included in twenty-seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Prednisolone acetate has twelve patent family members in ten countries.

There are eighty-eight drug master file entries for prednisolone acetate. Six suppliers are listed for this compound.

Drug Prices for PREDNISOLONE ACETATE

See drug prices for PREDNISOLONE ACETATE

Drug Sales Revenue Trends for PREDNISOLONE ACETATE

See drug sales revenues for PREDNISOLONE ACETATE

Recent Clinical Trials for PREDNISOLONE ACETATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Warrenville EyecarePhase 4
Ocular Therapeutix, Inc.Phase 2/Phase 3
Duke UniversityPhase 2/Phase 3

See all PREDNISOLONE ACETATE clinical trials

Pharmacology for PREDNISOLONE ACETATE

US Patents and Regulatory Information for PREDNISOLONE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering METIMYD prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 010210-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pharmafair PREDSULFAIR prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088007-001 Apr 19, 1983 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Allergan PRED FORTE prednisolone acetate SUSPENSION/DROPS;OPHTHALMIC 017011-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Cent Pharms PREDNISOLONE ACETATE prednisolone acetate INJECTABLE;INJECTION 084717-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PREDNISOLONE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 ⤷  Try it Free ⤷  Try it Free
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-002 Jan 17, 2008 ⤷  Try it Free ⤷  Try it Free
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-002 Jan 17, 2008 ⤷  Try it Free ⤷  Try it Free
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Colorcon
Harvard Business School
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.